ArticleCardiovascular drugs and therapy2022

Empagliflozin Disrupts a Tnfrsf12a-Mediated Feed Forward Loop That Promotes Left Ventricular Hypertrophy.

Veera Ganesh Yerra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.